Article

COVID-19: How Orbis International is managing operations

Author(s):

Alex Delaney-Gesing

Danny Haddad, MD, chief of program at Orbis International, shares an update on how the company's operations have shifted during the coronavirus pandemic, as well as the record-breaking impact on one of its telehealth platforms.
 


See more coronavirus coverage here

 

Related Videos
Early monoclonal antibody treatment of COVID-19 beneficial for high-risk COVID-19 patients
Sunir J. Garg, MD, speaks on the influence of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-VEGF injections.
Related Content
Increased number of acute macular neuroretinopathy cases associated with COVID-19 pandemic
November 4th 2024

Increased number of acute macular neuroretinopathy cases associated with COVID-19 pandemic

Reflecting on life during a pandemnic
June 14th 2021

Reflecting on life during a pandemnic

Long-term effects of COVID-19 on the ocular surface
August 16th 2024

Long-term effects of COVID-19 on the ocular surface

Adjusting ophthalmology practice to a pandemic
April 19th 2021

Adjusting ophthalmology practice to a pandemic

Study examines the impact of the COVID-19 pandemic on ophthalmology residency and fellowship training
July 29th 2024

Study examines the impact of the COVID-19 pandemic on ophthalmology residency and fellowship training

AI, big data, and personalized medicine: Scientists reveal playbook designed to revolutionize healthcare
May 30th 2024

AI, big data, and personalized medicine: Scientists reveal playbook designed to revolutionize healthcare

© 2024 MJH Life Sciences

All rights reserved.